Skip to main content
JAMA Network logoLink to JAMA Network
. 2018 May 16;3(5):445. doi: 10.1001/jamacardio.2018.1067

Error in Author Byline

PMCID: PMC8177323  PMID: 29800134

In the Original Investigation titled “Ticagrelor vs Clopidogrel After Fibrinolytic Therapy in Patients With ST-Elevation Myocardial Infarction: A Randomized Clinical Trial,”1 published online March 11, 2018, there were errors in the author byline. Instead of “The Writing Committee for the TREAT Study Group,” the author byline should read as follows: “Otavio Berwanger, MD, PhD; Jose C. Nicolau, MD, PhD; Antonio C. Carvalho, MD, PhD; Lixin Jiang, MD, PhD; Shaun G. Goodman, MD, PhD; Stephen J. Nicholls, MD, PhD; Alexander Parkhomenko, MD, PhD; Oleg Averkov, MD, PhD; Carlos Tajer, MD, PhD; Germán Malaga, MD, PhD; Jose F. K. Saraiva, MD, PhD; Francisco A. Fonseca, MD, PhD; Fábio A. De Luca, MD, PhD; Helio P. Guimaraes, MD, PhD; Pedro G. M. de Barros e Silva, MD, MHS, PhD; Lucas P. Damiani, MSc; Denise M. Paisani, PhD; Camila M. R. Lasagno, BSc; Carolina T. Candido, PharmD; Nanci Valeis, Dr; Diogo D. F. Moia, PharmD; Leopoldo S. Piegas, MD, PhD; Christopher B. Granger, MD, PhD; Harvey D. White, MD, PhD; Renato D. Lopes, MD, MHS, PhD; for the TREAT Study Group.” This article was corrected online.

Reference

  • 1.Berwanger O, Nicolau JC, Carvalho AC, et al. Ticagrelor vs clopidogrel after fibrinolytic therapy in patients with st-elevation myocardial infarction: a randomized clinical trial [published online March 11, 2018]. JAMA Cardiol. doi: 10.1001/jamacardio.2018.0612 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from JAMA Cardiology are provided here courtesy of American Medical Association

RESOURCES